Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/24/2868758/0/en/Regeneron-to-Showcase-Progress-in-Advancing-Novel-Investigational-Treatment-Approaches-for-a-Broad-Range-of-Solid-Tumors-and-Blood-Cancers-at-ASCO.html
https://www.globenewswire.com/news-release/2024/04/22/2867279/0/en/Regeneron-to-Highlight-Advances-in-Genetic-Medicine-Research-at-American-Society-of-Gene-and-Cell-Therapy-ASGCT.html
https://endpts.com/nvidias-biotech-moment-regeneron-launches-venture-arm-new-glp-1-player-enters-sanofi-rejigs-cancer-pact-vaccine-ops-and-more/
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-warns-harmful-reactions-fake-botox-injections-2024-04-16/
https://www.biospace.com/article/regeneron-launches-500m-venture-capital-fund-skewed-toward-biotech/
https://www.reuters.com/legal/us-justice-department-files-complaint-against-regeneron-alleges-fraudulent-drug-2024-04-10/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761055
https://www.globenewswire.com/news-release/2024/04/07/2858843/0/en/Linvoseltamab-Pivotal-Data-Presented-at-AACR-Reinforce-High-Response-Rate-that-Deepens-Over-Time-in-Patients-with-Heavily-Pre-Treated-Multiple-Myeloma.html
https://www.globenewswire.com/news-release/2024/04/01/2855420/0/en/Regeneron-to-Report-First-Quarter-2024-Financial-and-Operating-Results-and-Host-Conference-Call-and-Webcast-on-May-2-2024.html